Chrisy Ngilneii's Profile

B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)

Chrisy Ngilneii

Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on view more..

Written / Edited / Medically Reviewed

First Subunit Tuberculosis Vaccine Shows Potential to Protect

First Subunit Tuberculosis Vaccine Shows Potential to Protect

Tuberculosis vaccine trial results offer potential for BCG Revaccination and subunit vaccines. It is the first 'prevention of infection' trial conducted for TB.

Health Watch
Gene Editing - Potential Treatment for Sickle Cell Disease

Gene Editing - Potential Treatment for Sickle Cell Disease

Gene editing is a potential treatment for sickle cell disease, states a research presented at the 2018 AAAS Annual Meeting.

Health Watch
Calcium Surplus in Brain Cells may Cause Parkinson’s Disease

Calcium Surplus in Brain Cells may Cause Parkinson’s Disease

Calcium may play a role in the development of Parkinson's disease. Excess levels of calcium in brain cells may lead to the formation of toxic clusters.

Health Watch
Effects of Tobacco on Women’s Reproductive Health: Hear It From a Renowned Gynaecologist

Effects of Tobacco on Women’s Reproductive Health: Hear It From a Renowned Gynaecologist

Effects of tobacco on women’s reproductive health as explained by Dr.Duru Shah, Scientific Director, Gynaecworld & Gynaecworld Assisted Fertility Center.

Medindia Exclusive - Interviews and In depth Reports
Epilepsy Drug Levetiracetam may be Better Than Phenobarbital

Epilepsy Drug Levetiracetam may be Better Than Phenobarbital

Most commonly prescribed drug for infantile epilepsy Levetiracetam, may also be more effective than its competing drug Phenobarbital

Health Watch